Ready to go from discovery to IND filing for #CRISPRtherapies? In our new Decoded™ article, we highlight the complex, global regulatory frameworks necessary to accelerate your journey to the clinic. Read more: https://idtb.io/crh3u3
#CRISPR #RA #CRISPRtherapy #geneediting
IDT President Ajay Gannerkote discusses the many ways IDT is driving #genomics forward—from our #syntheticbiology custom solutions, to supporting the development of the world’s first personalized #CRISPR therapy. Read more in his article here: bit.ly/461yQkr
#genomicsnews #NGS #CRISPRtherapy
These expanded solutions are designed to help researchers accelerate more CRISPR-based therapies for patients like KJ Muldoon, an infant who suffered CPS1 deficiency and made history when he received the world’s first personalized #CRISPRtherapy supported by IDT and Aldevron. Read on: idtb.io/is2ebq
The Star Tribune reports that the University of Minnesota is continuing its development of a CRISPR-edited immunotherapy for colon cancer, despite losing financial backing from biotech startup Intima Bioscience.
#AccessPress #StarTribune #CancerResearch #CRISPRTherapy #MN #Minnesota